![]() |
市场调查报告书
商品编码
1627797
全球非基因改造大豆市场:预测(2025-2030)Global Non-GMO Soybean Market - Forecasts from 2025 to 2030 |
全球非基因改造 (GMO) 大豆市场预计在预测期内将以 3.74% 的年复合成长率(CAGR)增长。
有几个关键因素正在推动非基因改造大豆市场的成长。第一个驱动因素是消费者对基改作物潜在健康风险的担忧增加。对过敏性、抗生素抗药性以及对人类健康的广泛影响的担忧导致许多人积极寻求非基因改造替代品,例如非基因改造大豆。
此外,非基因改造大豆的生产通常与更永续的农业实践相关,例如减少农药和除草剂的使用以及促进生物多样性。此外,一些国家也限製或彻底禁止使用基因改造产品,为非基因改造大豆生产商创造了利润丰厚的出口机会,并扩大了全球市场。
特别是美国是最大的大豆出口国之一,2023年产量为49吨。美国农业部估计,美国约有 440 万英亩土地专门用于种植非基因改造大豆,到 2022 年,87,455,000 英亩大豆总面积中的 1,924,010 英亩将分配给非基因大豆种植。
此外,人们对基因改造标籤法规的认识不断提高,一些国家对基因改造产品实施强制标籤。这种透明度的提高可以使消费者做出明智的选择,并导致对大豆等非基因改造食品的需求增加。
非基因改造大豆市场的驱动因素
越来越多的消费者开始采用素食、纯素和弹性素食饮食,推动对植物蛋白替代品的需求大幅成长。非基因改造大豆以其多功能性和成本效益而闻名,使其成为许多植物性肉类替代品、乳製品替代品和各种其他食品的关键成分。
根据欧盟委员会最近发布的报告,欧盟27国大豆种植面积预计将扩大30%,从2023年的100万公顷达到2035年的130万公顷。
报告预测,2023 年至 2035 年间,欧盟境内的土地用途将发生重大转变,从种植谷物转向种植大豆和豆类。这些土地利用变化是由于对作为饲料的谷物的需求下降、促进轮作和蛋白质作物种植的政策奖励、对植物蛋白和当地产品的需求增加、非转基因标籤产品的激增,这这是由多种因素推动的,包括转向不毁林的大豆生产。
此外,消费者越来越重视消费动物性蛋白质对健康的影响以及畜牧业对环境的影响。与传统的动物性蛋白质来源相比,非基因改造大豆被认为是更健康、更永续的替代蛋白质来源。
非基因改造大豆市场的地理展望
从区域来看,市场分为北美、南美、欧洲、中东/非洲和亚太地区。由于商品大豆价格低廉、溢价诱人以及基改大豆种子成本上升,美国农民正在增加非基改大豆的种植面积。大学代表、粮食买家和大豆协会代表均表示,随着非基因改造大豆需求的增加,非基因改造大豆的种植面积将会增加。自采用以来,基改抗农达大豆已占美国大豆种植面积的大部分。
在美国,2021年种植的8,720万英亩大豆中,有440万英亩将种植非基因改造作物。相较之下,2022 年和 2020 年预计面积分别为 410 万英亩和 500 万英亩。美国大豆种植者种植了约 260 万英亩食品级大豆,这些大豆被出售用于豆腐、豆奶、味噌、纳豆和豆芽等用途。剩余的170万英亩土地被用作饲料大豆。
此外,国际企业的进入预计将进一步提振国内非基因改造大豆需求。例如,2024 年 1 月,密苏里州大豆商品行销委员会和以其优质机会和遗传多样性而闻名的 Beck's 宣布了一项 SOYLEIC® 大豆的战略授权合约。透过利用 Beck 的广泛网络,这项合作关係将使高油酸 (HO) 产业受益,并完美补充 SOYLEIC® 为大豆农民提供 HO 基因的目标。
与传统油相比,高油酸大豆油具有许多优点和一些理想的特性。来自美国的高油酸大豆油可改善脂肪分布,增加中性风味,延长产品保存期限,让您的食物成为焦点。它还提供所有食用油中最长的煎炸时间。此外,SOYLEIC(R) 是目前市面上其他高油酸大豆品种中唯一的非基因改造大豆品种。
此外,2022 年 2 月,解锁植物遗传多样性的食品科技公司 Benson Hill, Inc. 宣布推出具有特殊永续性优势的国产非基因改造植物蛋白成分新系列 TruVailTM。 TruVailTM 品牌提供的首批产品是高蛋白大豆粉、大豆浓缩蛋白 (SPC) 的低加工版本,以及可用于传统大豆蛋白以及快速大豆蛋白的多种应用的组织化蛋白。替代植物性蛋白质市场。
为什么要购买这份报告?
它有什么用?
产业和市场考量、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响。
The global non-genetically modified organisms (GMO) soybean market is anticipated to grow at a compound annual growth rate (CAGR) of 3.74% over the forecast period.
Several significant factors are driving the global non-GMO soybean market growth. A primary driver is the increasing consumer concern regarding the potential health risks associated with GMOs. Worries about allergenicity, antibiotic resistance, and broader implications on human health are prompting many individuals to actively seek out non-GMO alternatives, such as non-GMO soybeans.
Additionally, non-GMO soybean production is often associated with more sustainable farming practices, including reduced pesticide and herbicide usage, as well as the promotion of biodiversity. Furthermore, some countries have implemented restrictions or outright bans on GMO products, creating lucrative export opportunities for non-GMO soybean producers and thereby expanding the global market.
Notably, the United States stands as one of the largest exporters of soybeans, with a production of 49 metric tons in 2023. The USDA estimates that approximately 4.4 million acres in the U.S. are dedicated to non-GMO soybean cultivation, and 1,924,010 will be given to non-GMO food-grade soybeans out of a total soybean acreage of 87,455,000 in 2022.
Moreover, there is a growing awareness surrounding GMO labeling regulations, with some countries mandating labeling requirements for GMO products. This increased transparency empowers consumers to make informed choices and can lead to heightened demand for non-GMO options like soybeans.
Global non-GMO soybean market drivers
A growing number of consumers are embracing vegetarian, vegan, or flexitarian diets, which has spurred a significant uptick in the demand for plant-based protein alternatives. Non-GMO soybeans, renowned for their versatility and cost-effectiveness, serve as a pivotal ingredient in numerous plant-based meat substitutes, dairy alternatives, and various other food products.
According to a recent report published by the European Commission, it is projected that the soybean cultivation area within the EU-27 will witness a 30% expansion, reaching 1.3 million hectares by 2035, up from 1.0 million hectares in 2023.
The report anticipates a notable shift in land utilization within the EU, with a transition from cereals to soybeans and pulses between 2023 and 2035. This shift in land use is driven by several factors, including anticipated reduced demand for cereals as feed, policy incentives promoting crop rotation and the cultivation of protein crops, escalating demand for plant-based proteins and local products, a surge in GMO-free labeled products, and a push towards deforestation-free soybean production.
Further, consumers are increasingly prioritizing concerns regarding the health implications of animal protein consumption and the environmental footprint of animal agriculture. Non-GMO soybeans are perceived as a healthier and more sustainable alternative protein source compared to traditional animal-derived protein sources.
Global non-GMO soybean market geographical outlook
Based on geography, the global baby body care market is segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. American farmers are planting more non-GMO soybeans due to low commodity soybean prices, attractive premiums, and rising costs for genetically modified soybean seed. University representatives, grain buyers, and soybean association representatives all state that as demand for non-GMO soybeans rises, more non-GMO acres will be planted. Since their introduction, genetically modified Roundup Ready soybeans have accounted for a growing portion of US soybean acreage annually.
In the United States, 4.4 million of the 87.2 million soybean acres planted in 2021 are non-GMO. This is contrasted with an estimated 4.1 million in 2022 and 5 million in 2020. About 2.6 million acres were planted by American soy farmers with food-grade soybeans, which are sold for tofu, soymilk, miso, natto, sprouts, and other uses. Feed-grade soy covered the remaining 1.7 million acres of non-GMO soy.
In addition, expansion ventures by international players into the market are further expected to boost the non-GMO soybeans demand in the country. For instance, in January 2024, the Missouri Soybean Merchandising Council and Beck's, renowned for their premium opportunities and diverse genetics, announced a strategic licensing agreement with SOYLEIC(R) soybeans. By utilizing Beck's extensive network, this partnership benefits the high oleic (HO) sector and perfectly complements SOYLEIC(R)'s objective of providing soybean farmers with access to HO genetics.
In contrast to conventional oils, high oleic soybean oil offers numerous advantages and several desirable characteristics. American-grown high-oleic soybean oil improves the fat profile, adds a neutral flavor, prolongs the shelf life of products, and lets the food take center stage. It also offers some of the longest fry times of any edible oil. Furthermore, SOYLEIC(R) is the only non-GMO soybean variety currently offered, even though there are other high oleic varieties on the market.
Moreover, in February 2022, TruVailTM, a new line of domestically sourced, non-GMO plant-based protein ingredients with special sustainability benefits, was introduced by Benson Hill, Inc., a food technology company that is unlocking the genetic diversity of plants. The first products offered by the TruVailTM brand are high-protein soy flour, a less processed version of soy protein concentrate (SPC), and texturized proteins that can be used in a variety of conventional soy protein applications as well as the quickly expanding markets for alternative plant-based proteins.
Reasons for buying this report:-
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence